Managing the risk


PDL outlines preparation and risk management considerations for the paediatric Pfizer vaccine The approval of the Pfizer Comirnaty Orange Cap (5-11 years) COVID-19 vaccine to be administered by pharmacists from 10 January 2022 offers opportunities and challenges for pharmacists. PDL encourages pharmacists to prepare for this service now and consider the following to minimise risk.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next Pharmacy at the centre of testing imbroglio